§ Funding Round
Series C funding round for Checkmate Pharmaceuticals raising $85M in June 2020
Series C funding round for Checkmate Pharmaceuticals raising $85M in June 2020
| Investor | Firm Type | Partner |
|---|---|---|
Andreessen Horowitz | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | carol gallagher | |
| Organization | — | |
Omega Funds | — | — |
| Organization | — | |
SV Health Investors | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | james park | |
| Angel | Jason Wang | |
| Angel | jon brelig | |
| Angel | manik gupta | |
| Angel | Ralph Gootee | |
| Organization | — | |
| Organization | — | |
F-Prime Capital | — | — |
| Angel | oren k. isacoff, m.d. | |
| Organization | — | |
nilesh kumarLEAD | Angel | nilesh kumar |
| Organization | — | |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$176M
Top Valuation
-
Checkmate Pharmaceuticals raised $85M in a Series C round.
The round was announced on 06/01/20.
The round was led by oren k. isacoff, m.d., nilesh kumar.
